Elken Medical Holdings Co., Ltd. (“Elken Healthcare” or the “Company”) commercializes 3D printing technology and applies it to bone, joint and spine replacement implants, and occupies a leading position in the Chinese bone and joint implant market. Elken Healthcare designs, develops, manufactures and sells orthopedic implants, and focuses on hip and knee replacement implants. Elken Medical's products include bone and joint implants specifically designed to replace, repair, or upgrade implants or components of previous surgeries. As a distributor, Elken Medical also sells orthopedic products produced by third parties to supplement the company's product portfolio to customers.
Elken Medical sells its products under the “Elken” brand name. After years of development, it has become the best-selling intraarticular implant brand in China. In terms of revenue in 2017, “Elken” is also the best-selling domestic orthopedic implant brand.
Elken Medical developed a personalized 3D precision construction technology solution (“3D ACT Solution”) in July 2014. 3D ACT solutions help surgeons simulate and plan surgeries, simplify surgical procedures, provide personalized surgical instruments and selected implants prior to surgery, and significantly improve patients' recovery progress. Elken Medical's conventional products and 3D printed products are regulated by the Food and Drug Administration. Currently, the company's three 3D printed products include hip replacement implants, spinal intervertebral fusions, and artificial vertebral bodies. Elken Medical is a one-stop orthopedic surgery solution company that combines all four services, including 3D imaging and 3D modeling, providing 3D printed models and formulating customized surgical plans for patients, producing 3D printed surgical instruments, and producing 3D printed bone and joint replacement implants.
Elken Healthcare has an extensive and growing nationwide distribution network. As of December 31, 2017, Elken Medical had more than 650 distributors of products, covering all provinces of China and 23 overseas jurisdictions. The company also sells some products directly to hospitals through wholly-owned subsidiaries holding relevant distributor licenses. The Company mainly maintains such direct sales to establish and maintain direct contacts with several of the Company's major end hospital clients and surgeons.
CEO： Zhijiang Li
Market： Hong Kong motherboard
Listing Date： 12/20/2017